References
- Lewinsohn PM, Klein DN, Seeley JR: Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disord 2000; 2(3 pt 2):281–293
- James AC, Javaloyes AM: The treatment of bipolar disorder in children and adolescents. J Child Psychol Psychiatry 2001; 42:439–449
- Faedda GL, Baldessarini RJ, Suppes T, Tondo L, Becker I, Lipschitz DS: Pediatric-onset bipolar disorder: a neglected clinical and public health problem. Hari, Rev Psychiatry 1995; 1995:171–195
- Pliszka SR, Sherman JO, Barrow MV, hick S: Affective disorder in juvenile offenders: a preliminary study. Am J Psychiatry 2000; 157:130–132
- Belmaker RH: Bipolar disorder. N Engl J Med 2004; 351:476–486
- Weisler RH, Kalali AH, Ketter TA, and the 5PD417 Study Group: A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004; 65:478–484
- Weisler RH, Keck PE Jr, Swann AC, Cutler AJ, Ketter TA, Kalali AH, for the 5PD417 Study Group: Extended-release carbam-azepine capsules as monotherapy for acute mania in bipolar disor-der: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2005; 66:323–330
- Post RM, Denicoff K, Frye MA: Reevaluation of carbamazepine prophylaxis in bipolar disorder. Br J Psychiatry 1997; 170:202–204
- Stigler KA, Potenza MN, McDougle CJ: Tolerability profile of atypical antipsychotics in children and adolescents. Paediatr Drugs 2001; 3:927–942